Multicenter, observational, descriptive study of the diagnosis, course and treatment of patients with SLE in routine practice in Kazakhstan: a registry study with retrospective and prospective components.

Trial Identifier: D3461R00087
Sponsor: AstraZeneca
Start Date: May 2025
Primary Completion Date: February 2027
Study Completion Date: February 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Kazakhstan Aktobe, Kazakhstan
Kazakhstan Almaty, Kazakhstan
Kazakhstan Astana, Kazakhstan
Kazakhstan Pavlodar, Kazakhstan
Kazakhstan Semey, Kazakhstan
Kazakhstan Shymkent, Kazakhstan
Kazakhstan Taldykorgan, Kazakhstan
Kazakhstan Taraz, Kazakhstan, -- Select --